Recital 6, Regulation (EU) 2023/2210

In forcesince 20 Oct 2023

On 25 March 2021, the applicant also made a request to the Commission for the protection of proprietary scientific studies and data submitted in support of the application, namely, high performance liquid chromatography-electrospray ionisation-mass spectrometry (‘HPLC-ESI-MS/MS’), nuclear magnetic resonance (‘NMR’) spectroscopy, and high-performance anion-exchange chromatography with pulsed amperometric detection (‘HPAEC-PAD’) method validation and the results for the determination of the identity of 3-FL [Glycom A/S 2021 and 2022 (unpublished).]; a detailed description of the genetically modified 3-FL production strain [Glycom A/S 2021 and 2022 (unpublished).]; a detailed description of the production process [Glycom A/S 2021 and 2022 (unpublished).]; detailed composition analysis and stability test results [Glycom A/S 2021 (unpublished).]; a bacterial reverse mutation test with 3-FL [Phipps KR, Lozon D, Stannard DR, Gilby B, Baldwin N, Miks MH, Lau A and Röhrig CH, 2022. Neonatal subchronic toxicity and in vitro genotoxicity studies of the human-identical milk oligosaccharide 3-fucosyllactose. Journal of Applied Toxicology, 2022, 1–17.]; an in vitro mammalian cell micronucleus test with 3-FL [Phipps KR, Lozon D, Stannard DR, Gilby B, Baldwin N, Miks MH, Lau A and Röhrig CH, 2022. Neonatal subchronic toxicity and in vitro genotoxicity studies of the human-identical milk oligosaccharide 3-fucosyllactose. Journal of Applied Toxicology, 2022, 1–17.]; a 14-day dose range finding oral toxicity study in rats with 3-FL [Phipps KR, Lozon D, Stannard DR, Gilby B, Baldwin N, Miks MH, Lau A and Röhrig CH, 2022. Neonatal subchronic toxicity and in vitro genotoxicity studies of the human-identical milk oligosaccharide 3-fucosyllactose. Journal of Applied Toxicology, 2022, 1–17.]; and, a 90-day oral toxicity study in rats with 3-FL [Phipps KR, Lozon D, Stannard DR, Gilby B, Baldwin N, Miks MH, Lau A and Röhrig CH, 2022. Neonatal subchronic toxicity and in vitro genotoxicity studies of the human-identical milk oligosaccharide 3-fucosyllactose. Journal of Applied Toxicology, 2022, 1–17.].